Abstract
These NCCN Guidelines Insights highlight treatment recommendations and updates specific to the management of patients with advanced non-clear cell carcinoma included in the 2014 version of the NCCN Clinical Practice Guidelines in Oncology for Kidney Cancer.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Humans
-
Kidney Neoplasms / diagnosis
-
Kidney Neoplasms / drug therapy*
-
Molecular Targeted Therapy
-
Protein Kinase Inhibitors / therapeutic use*
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors